Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Profit After Tax

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹1,941 Cr₹130,968 Cr₹1,453 Cr₹129 Cr₹10,561 Cr

What is the latest Profit After Tax of MANKIND PHARMA ?

The latest Profit After Tax ratio of MANKIND PHARMA is ₹1,941 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹1,941 Cr
Mar2024₹130,968 Cr
Mar2023₹1,453 Cr
Mar2022₹129 Cr
Mar2021₹10,561 Cr

How is Profit After Tax of MANKIND PHARMA Trending?

Years Profit After Tax % Change
Mar2025 ₹1,941 Cr
-98.52
Mar2024 ₹130,968 Cr
8,913.86
Mar2023 ₹1,453 Cr
1,023.68
Mar2022 ₹129 Cr
-98.78
Mar2021 ₹10,561 Cr -

Compare Profit After Tax of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹103,361.0 Cr 1.4% 18% -1.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.4% 10.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 0.7% 9.5% 16.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr -2.5% 6% 36.2% Stock Analytics
CIPLA ₹115,641.0 Cr 9.7% 16.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 4.5% 9.7% 9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.4%

18%

-1.4%

SENSEX

-2.7%

-2.1%

-5.3%


You may also like the below Video Courses